(RTTNews) - Alexion Pharmaceuticals (ALXN: News ) reported third quarter EPS of $0.37 Thursday morning, which came in above the consensus estimate of $0.21. The company also increased its full year EPS forecast to between $1.15 and $1.18, from prior guidance of $1.01 to $1.06.

Alexion Pharmaceuticals gapped up sharply Thursday and climbed in early trade. Shares rose further late in the afternoon and closed higher by $3.68 at $47.81 on the highest volume in nearly 4 months. The stock broke out of a 2-month range and set a new high for the year.

Click here to receive FREE breaking news email alerts for Alexion Pharmaceuticals Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com